Nonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: a predominance of musculoskeletal pain. [electronic resource]
Producer: 20150423Description: e111-3 p. digitalISSN:- 1536-3678
- Adolescent
- Adult
- Antineoplastic Agents -- adverse effects
- Benzamides -- adverse effects
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Humans
- Imatinib Mesylate
- Infant
- Infant, Newborn
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Musculoskeletal Pain -- chemically induced
- Piperazines -- adverse effects
- Prognosis
- Pyrimidines -- adverse effects
- Retrospective Studies
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.